Polyphosphate nanoparticles enhance the fibrin stabilization by histones more efficiently than linear polyphosphates

Introduction Beyond the three-dimensional fibrin network, the mechanical and lytic stability of thrombi is supported by the matrix of neutrophil extracellular traps (NETs) composed of polyanionic DNA meshwork with attached proteins including polycationic histones. Polyphosphates represent another type of polyanions, which in their linear form are known to enhance the fibrin stabilizing effects of DNA and histones. However, in vivo polyphosphates are also present in the form of nanoparticles (PolyP-NP), the interference of which with the fibrin/NET matrix is poorly characterized. Aims To compare the effects of linear and nanoparticulate polyphosphates, and their combinations with relevant NET components (DNA, histone H3) on fibrin formation, structure, and lysis in in vitro assays focusing on histone-polyphosphate interactions. Methods Transmission electron microscopy and dynamic light scattering for stability of the PolyP-NP preparations. Turbidimetry for kinetics of fibrinogen clotting by thrombin and fibrin dissolution by tissue-type plasminogen activator/plasminogen. Scanning electron microscopy for fibrin structure. Surface plasmon resonance for strength of histone-PolyP interactions. Results Both linear PolyP and PolyP-NP accelerated the fibrin formation and slowed down its dissolution and these effects were strongly dependent on the number of individual PolyP particles and not on their size. Addition of DNA did not modify significantly the PolyP-NP effects on fibrin formation and lysis. Both linear and nanoparticulate PolyP counteracted the effect of histone in the acceleration of fibrinogen clotting by thrombin. PolyP-NP, but not linear PolyP enhanced the prolongation of lysis time in fibrin containing histone and caused more pronounced thickening of the fibrin fibers than the linear form. Finally, PolyP-NP bound weaker to histone than the linear form. Conclusions The interaction of PolyP with histone was a stronger modulator of fibrin formation and lysis than its interaction with DNA. In addition, the PolyP nanoparticles enhanced the thrombus stabilizing effects of histone more effectively than linear PolyP.


Introduction
Beyond the three-dimensional fibrin network, the mechanical and lytic stability of thrombi is supported by the matrix of neutrophil extracellular traps (NETs) composed of polyanionic DNA meshwork with attached proteins including polycationic histones. Polyphosphates represent another type of polyanions, which in their linear form are known to enhance the fibrin stabilizing effects of DNA and histones. However, in vivo polyphosphates are also present in the form of nanoparticles (PolyP-NP), the interference of which with the fibrin/NET matrix is poorly characterized.

Aims
To compare the effects of linear and nanoparticulate polyphosphates, and their combinations with relevant NET components (DNA, histone H3) on fibrin formation, structure, and lysis in in vitro assays focusing on histone-polyphosphate interactions.

Methods
Transmission electron microscopy and dynamic light scattering for stability of the PolyP-NP preparations. Turbidimetry for kinetics of fibrinogen clotting by thrombin and fibrin dissolution by tissue-type plasminogen activator/plasminogen. Scanning electron microscopy for fibrin structure. Surface plasmon resonance for strength of histone-PolyP interactions.

Results
Both linear PolyP and PolyP-NP accelerated the fibrin formation and slowed down its dissolution and these effects were strongly dependent on the number of individual PolyP particles and not on their size. Addition of DNA did not modify significantly the PolyP-NP effects on fibrin formation and lysis. Both linear and nanoparticulate PolyP counteracted the effect of

Introduction
Neutrophil extracellular traps (NETs) and polyphosphates (PolyPs) are both known as key players of (immuno)thrombosis. Their procoagulant and prothrombotic nature, as well as their interactions in circulation have been recently reviewed in detail [1]. Our previous studies on the effects of NET components on structural and lytic stability of fibrin and plasma clots revealed that DNA, histones and their combinations increase the mechanical stability of clots and hamper tissue-type plasminogen activator (tPA) mediated clot lysis [2,3]. Furthermore, we found, that linear PolyPs stabilize fibrin via size-dependent modulation of its structure and kringle-dependent inhibition of plasmin-mediated fibrinolysis [4], while in combination with NET components, linear PolyPs enhanced the clot stabilizing effects of DNA and histones [5].
In addition to the linear form, nanoparticulate polyphosphates (PolyP-NPs) have also been shown to localize at the surface of activated platelets and activate the intrinsic pathway of coagulation [6], but in contrast to the linear PolyP effects, little is known about their contribution to the stabilization of thrombi by NETs.
In this study, we aimed 1) to develop a new method for preparing stable, pure PolyP-NPs that are suitable for in vitro applications to study their role in hemostasis, and 2) to compare and characterize the effects of the linear and nanoparticulate forms of PolyPs and the combined effects of DNA, histones and PolyPs on the kinetics of clotting, structure and lytic susceptibility of fibrin clots in vitro.

Materials and methods
Plasminogen depleted human fibrinogen, alkaline phosphatase, short-chain polyphosphate (PolyP-Lin-45 with an average polymer length of 45 monomers), histones from calf thymus type VIIIS (arginine-rich histone H3) were obtained from Merck Kft. (Budapest, Hungary). Polyphosphate, Medium Chain (PolyP-Lin-100) and Polyphosphate, Long Chain (PolyP-Lin-700) were from Kerafast (Boston, MA, USA). Bovine thrombin was purchased from Serva (Heidelberg, Germany) and further purified by ion-exchange chromatography on sulfopropyl-Sephadex yielding a preparation with a specific activity of 2,100 IU/mg [7] and 1 IU/ml was considered equivalent to approximately 10.7 nM by active site titration [8]. Plasminogen and plasmin were prepared as previously described [9]. as follows. Ca 2+ -PolyP nanoparticles were generated by adding linear PolyP 45 (1 mM) to CaCl 2 (1.67 mM) in BSA-TBS buffer (8 mM Tris-HCl, pH 9, containing 1 mg/ml bovine serum albumin). Ca 2+ -precipitation was allowed to proceed at room temperature for 20 min under continuous vigorous stirring to achieve homogeneity. Thereafter large aggregates were dispersed by ultrasound sonication with a Branson Sonifier 250 (BRANSON Ultrasonics Corp., Danbury, CT, USA) for 10 min (20 kHz horn frequency, 65 W) with a 5-min pause at half-time. Remnant large aggregates were removed by filtrating them sequentially through a syringe filter of 1.2 μm and then through a filter of 0.22 μm pore size. Finally, the filtrate with the remaining PolyP-NPs was retained and stored at 4˚C.

Determination of phosphate monomer and polyphosphate nanoparticle concentration
The phosphate monomer concentration of both linear and nanoparticulate polyphosphates was determined by a modified version of the Fiske-Subbarow method [12]. Alkaline phosphatase (20 U/l) was added to polyphosphate solutions and mixtures were incubated for 2 hours at 37˚C to cleave phosphate polymers to monomers. Then a mixture of 4.4%(w/v) ascorbic acid and 4.4%(w/v) trichloroacetic acid (TCA) was added to the samples followed by centrifugation for 2 min at 5,000g. The liquid phase was withdrawn and after the addition of 0.2%(w/v) ammonium molybdate the samples were incubated for 1 hour at 50˚C. Following the color reaction, the absorbance of the samples and a dilution series of NaH 2 PO 4 standard were measured in a CLARIOstar spectrophotometer (BMG Labtech, Ortenberg, Germany) at 700 nm. Particle concentration of the PolyP-NP preparations was estimated considering the phosphate monomer concentration of the samples, the average density of Ca 2+ -PolyP-NPs (3.14 g/cm 3 ) [13] and the radius of the particles calculated according to our transmission electron microscopy and dynamic light scattering measurements using sphere approximation [14]. The preparations of applied polyphosphates are summarized in Table 1.

Characterization of PolyP-NPs by transmission electron microscopy (TEM)
To visualize and to measure the size of the polyphosphate nanoparticles samples were mounted on Formwar-Carbon coated 300-mesh nickel grids (Nisshin EM Co. Ltd. Tokyo, Japan) and stained with 2%(w/v) uranyl acetate. Samples were examined using a JEOL JEM-1011 electron microscope (JEOL, Ltd., Tokyo, Japan) at an accelerating voltage of 80 kV. Images were taken by Morada 11 Megapixel camera (Olympus, Tokyo, Japan) using iTEM software (Olympus) [15].

Characterization of PolyP-NPs by dynamic light scattering (DLS)
The stability of polyphosphate nanoparticles was monitored by measuring the size distribution of PolyP-NP samples for 6 days with DLS. Furthermore, the average particle size was checked before each measurement to validate that the nanoparticle diameter is within the target range of 100-200 nm [6]. This was performed using an ALV goniometer with a Melles Griot diodepumped solid-state laser at 457.5 nm wavelength (type: 58 BLD 301). The intensity of the scattered light was measured at 90˚and the autocorrelation function was calculated using an IBM PC-based data acquisition system developed in the Department of Biophysics and Radiation Biology of Semmelweis University (Budapest, Hungary). Particle size distributions were determined by the maximum entropy method [16].

Turbidimetric measurements of fibrin formation and dissolution
In order to maximize the modulator effects we used the highest final PolyP concentration achievable in the reaction mixtures during the turbidimetric measurements which was 330 μM in terms of phosphate monomer that corresponds to 1.96×10 12 PolyP particle/l in terms of particle concentration. PolyPlin concentrations were set to match these values: PolyP-Lin p samples of 1. Formation and dissolution of fibrin clots were followed in 96-well microtiter plates by measuring the light absorbance at 340 nm at 37˚C with a CLARIOstar spectrophotometer (BMG Labtech, Ortenberg, Germany). Fibrinogen (7 μM) containing plasminogen (0.2 μM) was clotted by thrombin (2 nM) with or without the modulators (5 μg/ml DNA, 20 μM histone or the above-mentioned concentrations of PolyPs) and their combinations at 100 μl total volume. Regarding the different Ca 2+ content of our PolyP-Lin (0 mM) and PolyP-NP preparations (1.67 mM), Ca 2+ -free and Ca 2+ -bearing control samples were used. After turbidity reached the plateau phase 90 μl 140 nM tPA was layered on the surface to trigger lysis, and the measurement was continued until complete dissolution of the clots. Kinetics of clotting and lysis were characterized by the time to reach half-maximal turbidity on the ascending and descending part of the turbidimetric curves (clotting time 50 and lysis time 50 , respectively).

Characterization of the structure of fibrin clots by scanning electron microscopy (SEM)
Fibrinogen (7 μM) was clotted by thrombin (2 nM) in the presence of modulators and their combinations at the concentrations used in the turbidimetric measurements. After complete clotting, fibrin was washed 3 times with 100 mM Na-cacodylate pH 7.2 buffer and fixed in 1% (v/v) glutaraldehyde for 30 min, then dehydrated in a series of ethanol dilutions [20-96%(v/ v)], 1:1 mixture of 96%(v/v) ethanol/acetone and pure acetone followed by critical point drying with CO 2 in an E3000 Critical Point Drying Apparatus (Quorum Technologies, Newhaven, UK). The specimens were then mounted on adhesive carbon discs, sputter-coated with gold in an SC7620 Sputter Coater (Quorum Technologies) and images were taken with scanning electron microscope EVO40 (Carl Zeiss GmbH, Oberkochen, Germany). The images were analyzed to determine the diameter of the fibrin fibers as described previously [2,17].

Histone-fibrinogen gelation
Previous studies demonstrated the gelation of histone-fibrinogen mixtures and its consequences on maximal turbidity during clotting assays [18]. We investigated the impact of this phenomenon to avoid misleading interpretations of our results with histones. Fibrinogen at 7 μM was mixed with histones at various concentrations (in the range of 0-26 μM) in the presence or absence of 50 nM plasmin in 96-well titration plates and the turbidity of the samples was monitored by a CLARIOstar spectrophotometer at 340 nm for 150 min at 37˚C. Samples (10 μl) were withdrawn at 0, 60 and 150 minutes and treated with 90 μl 1%(w/v) sodium dodecyl sulfate (SDS) in 100 mM Tris-HCl, 100 mM NaCl, pH 8.2 and polyacrylamide gel electrophoresis (PAGE) was performed on a 4-15% gradient gel followed by silver staining.

Surface plasmon resonance (SPR) measurements of histone-PolyP interactions
The interaction of histone and PolyP was evaluated with surface plasmon resonance (SPR) technology on SR7500DC system (Reichert Technologies Life Sciences, NY, USA) with standard software SPRAutolink 1.1.14-T provided by the manufacturer for reporting and analyzing data. The running buffer was 10 mM HEPES-NaOH 150 mM NaCl pH 7.4 containing Tween-20 at 0.005 w/w% (HBS-T) in all experiments, except when PolyP-NP was measured, where 1.67 mM CaCl 2 was also added. One of the channels on a dextran coated gold chip (Reichert SR7000 chip, 500 kDa carboxymethyl-dextran, part. no. 13206066) was coated noncovalently with 0.25 mg/ml Histone H3 in 10 mM Na-acetate pH 5.5 at a flow rate of 25 μl/ min for 7 min [19]. After the coating, the chip was washed and equilibrated with the running buffer for~10 min. For the interaction measurements 1 mM PolyP solutions were injected at 25 μl/min flow rate for 7 min. Results are reported in relative units (RU) as a difference in the signal between the histone and the reference channels. After each measurement, the chip surface was stripped and regenerated using 6 M guanidine hydrochloride in unbuffered ultrapure water, injected at 25 μl/min for 7 min. Guanidine was chosen to prevent precipitation of Ca 2+ salts that is observed with more common stripping methods. The system was then washed with pure water and re-equilibrated with running buffer for a subsequent non-covalent coating step.

Statistical analysis
The distribution of the data on fiber diameter was analyzed using an algorithm described previously: theoretical distributions were fitted to the empirical data sets and compared using Kuiper's test and Monte Carlo simulation procedures running under MatlabR2018b (The Mathworks, Natick, MA) [20]. Kolmogorov-Smirnov test was used for statistical evaluation of differences in distribution of other experimental datasets in this report (Statistics and Machine Learning Toolbox v.11.4 of MatlabR2018b) at p<0.05.

Generation of stable polyphosphate nanoparticles
First, we aimed to develop a novel technique for preparing stable PolyP nanoparticles (PolyP-NP). Our method was based on previous work by Morrissey et al. with further modifications [10]. The structure and stability of the generated nanoparticles were investigated by TEM and DLS. According to TEM micrographs small, electron-dense Ca 2+ -polyphosphate nanoparticles were formed with diameters in the range of 80-150 nm (Fig 1A). The size of the particles according to DLS was similar: peak volume probabilities were observed at 110-200 nm particle size (Fig 1B). The slightly larger size values with DLS were probably due to differences in the hydration state of the samples: for TEM the samples were dehydrated, while in DLS samples preserved their hydration shell. The nanoparticle stability was monitored by measurements of the size distribution in the PolyP-NP preparation with DLS. Till the 6 th storage day no change in the median diameter of PolyP-NPs was observed suggesting that neither aggregation, nor disintegration of the PolyP-NPs occurred in the preparations for at least 5 days stored in CaCl 2 -BSA-TBS at 4˚C (Fig 2).

Fibrin formation and lysis in the presence of polyphosphates
All examined types of polyphosphate preparations (PolyP-Lin m , PolyP-NP, PolyP-Lin p ) decreased the clotting time 50 and increased the lysis time 50 , but the size of their effect differed

PLOS ONE
Fibrin stability and polyphosphates (Table 2). Despite the difference in particle size (large aggregates in PolyP-NP and isolated molecules of 45 monomers in PolyP-Lin p ) the magnitude of the effect on the time course of clotting and lysis was similar for the preparations with identical number of particles (PolyP-NP and Poly-P-Lin p ; 19 and 12% faster clotting, 1.76-, and 1.28-fold slower lysis, respectively, compared to the PolyP-free control). However, particles of the same structure exerted stronger effects at higher numbers (PolyP-Lin m vs. PolyP-Lin p ; 45 and 12% faster clotting, 3.08-, and 1.28-fold slower lysis, respectively). These data show that the modulation of the kinetics of fibrin formation and dissolution depends primarily on the number of individual PolyP particles and not on their size.  Mixture of fibrinogen (7 μM) and plasminogen (0.2 μM) was clotted by thrombin (2 nM) in the presence or absence of linear PolyP (PolyP-Lin m or PolyP-Lin p , 330 μM and 1.96×10 12 particle/l, respectively) or PolyP-NP (330 μM which corresponds to 1.

PLOS ONE
Fibrin stability and polyphosphates

Combined effects of DNA and polyphosphates on fibrin formation and lysis
In vivo blood clots are known to contain polyanions (e.g. PolyPs and DNA) and their interplay as modulators of blood clotting and lysis is potentially relevant and partially revealed [4,21]. According to our turbidimetry data, the presence of DNA neither altered clotting time 50 alone, nor modulated the enhancement of clotting by PolyPs (Fig 3A and 3C). In the fibrinolytic assay DNA behaved in a Ca 2+ -dependent manner. In a Ca 2+ -free milieu, DNA doubled the lysis time 50 similarly to PolyP-Lin m , but in combination the two polyanions did not show any additivity of their effects (Fig 3B and 3D). In the presence of Ca 2+ , the lysis was not affected by DNA, while PolyP-NP increased lysis time 50 by 45% and this anti-fibrinolytic effect was only slightly moderated by DNA.

Combined effects of histones and polyphosphates on fibrin formation and lysis
Similarly to extracellular DNA, histones play critical roles in host defense, exerting procoagulant, proinflammatory and antifibrinolytic effects (reviewed in [22]). Their known impact on

PLOS ONE
Fibrin stability and polyphosphates clotting and lysis kinetics was confirmed by our measurements showing a concentrationdependent decrease in clotting-, and prolongation of lysis times ( Table 3). The plausible, electric charge-dependent interplay of histones and polyphosphates during in vivo thrombus formation justifies comparative evaluation of the effect of histones with the histone+PolyP combinations on the kinetics of clotting and lysis. The effect of histone on clotting time (clotting time 50 decreased by 79% in a Ca 2+ -free and by 73% in a Ca 2+ -bearing milieu) was opposed by all of the polyphosphates: histone+-PolyP-Lin m , histone+PolyP-Lin p and histone+PolyP-NP combinations increased clotting time 50 3.3-, 2.5-and 1.6-fold, respectively, compared to histone's effect alone (Fig 4A and 4C). Histone's effect on lysis time 50 (a 4.1-fold increase in the absence of Ca 2+ and a 2.5-fold increase in the presence of Ca 2+ ) was not influenced by histone+PolyP-Lin m or histone+-PolyP-Lin p combinations, but it was enhanced by histone+PolyP-NP (Fig 4B and 4D). The PolyP-NP's effect on lysis time 50 (increase by 76%) was remarkably strengthened by histone (increased further by 118%). According to these findings we can conclude, that 1) in fibrin polymerization all types of polyphosphates oppose the accelerating effect of histone, but the histone effect is least hampered by PolyP-NP; 2) in fibrinolysis only the polyphosphate in nanoparticulate form (and not the linear one) acts in synergism with histones to inhibit the process.

Histone-fibrinogen aggregation and its effect on fibrinogen digestion by plasmin
During the investigation of the effects of histone alone or in combination with PolyPs on fibrinogen clotting and lysis, we observed increased turbidity at the onset of clot formation ( Fig 4A) and prolonged fibrin lysis time (Table 3, Fig 4D). Our results confirmed the earlier findings of histone-fibrinogen gelation: incubating fibrinogen with histone resulted in increasing histone-fibrinogen aggregation (Fig 5A), and fibrinogen became resistant to lysis by plasmin (Fig 5B) [18].

Combined effects of histones and polyphosphates on fibrin structure
The kinetics of fibrin formation are known to affect the ultimate clot architecture (fiber size, branching density, porosity), whereas the fibrin structure is an essential determinant of fibrinolysis (reviewed in [23]). According to the results reported in the preceding sections, histones (and not DNA) modulated significantly the polyphosphate effects on fibrin formation and lysis. Thus, modification of the fibrin structure in the presence of polyphosphates in combination with histones could be hypothesized as a mechanism underlying our current findings. We characterized one parameter of the fibrin structure-the fiber thickness. In line with our earlier results [2], histone itself increased the median fibrin fiber diameter by 19% (Fig 6C). Poly-P-Lin m and its combination with histone increased the fiber diameter by 13% and 23%, respectively (not shown). Ca 2+ itself reduced fiber diameter by 11%, while PolyP-NP and histone +PolyP-NP combination increased it by 23% and 28%, respectively. In summary, the examined modulators and their combinations all increased the fibrin fiber diameter, however to a different extent and the combination of a polyanionic modulator (polyphosphates in different form) and a polycationic modulator (histone) did not neutralize, but rather reinforced their standalone effects.

Histone-PolyP binding
We recorded the SPR sensorgrams of four different polyphosphate forms (nanoparticulate form and linear variants of three differently lengths) flowing over histone non-covalently immobilized on carboxymethyl-dextran surface in the SPR cell (Fig 7). We employed a noncovalent immobilization strategy to prevent chemical modifications of the histone that could change the positive charge of its lysine and arginine residues conceivable in the targeted interactions (as described elsewhere, [19]). This strategy also circumvented the potential problem of histone denaturation, as each run started with freshly immobilized histone material. Polyphosphates were applied at concentrations spanning the range 0.1-1 mM (concentration in monomeric phosphate equivalents) (S1 File). We found that the nanoparticle form interacted weakly with histone with estimated dissociation equilibrium constant in the millimolar range (S1 File), whereas the linear polyphosphate forms resulted in a decline in the signal (Fig 7). This latter finding is consistent with a strong linear polyphosphate-histone binding that partially stripped the surface of non-covalently attached histone. There was no significant difference between the linear polyphosphate forms of different size (45, 100 or 700 monomeric units) at equivalent monomeric phosphate concentrations. To sum up, all forms of polyphosphate were able to bind histone, but with a marked qualitative difference in the strength of binding of nanoparticulate and linear forms. The stripping effect could be of interest, if polyphosphates and histones interact under flow conditions in vivo. The diameters of 300 fibrin fibers were measured from each of 3 independent fibrin sample images and the probability density function (PDF) of the diameter values is shown. The empirical data are shown as a histogram with bins of equal area (each bin has equal product of density and span of data), whereas the grey line indicates the lognormal theoretical distribution that fitted best these data. All differences in the median fiber diameters were significant at p<0.05, according to Kuipers's test of the distributions [20]. https://doi.org/10.1371/journal.pone.0266782.g006

PLOS ONE
Fibrin stability and polyphosphates

Discussion
Neutrophil extracellular traps were first described as novel players of the innate immune system against bacterial infection [24]. In addition to NETosis, neutrophils contribute to the localization of microbial infection by promoting blood coagulation [21]. Furthermore, there is growing evidence that NETs are key players in the formation of pathological thrombi [25]. In our previous works we focused on the effects of NET components (histones and DNA) on thrombus formation, structure and stability [2,3,26]. Besides DNA, another biorelevant, negatively charged polyanion, polyphosphate emerged as a potential modulator of thrombus formation and clot lysis during the last decade [1]. Polyphosphates are stored within the cells in the presence of divalent metal ions and upon platelet activation Ca 2+ -precipitated PolyPs are released in addition to the soluble, linear form. PolyP-NPs are proven to associate to platelet membrane and to be more potent activators of the contact pathway of blood coagulation than the linear form [6]. This finding raised the need to compare the effects of these two forms of polyphosphates on thrombus formation. Multifaceted interactions of linear polyphosphates with thrombogenic factors have been observed. Linear polyphosphates accelerate blood clotting by activating the contact pathway and activation of factor V, which counteracts the action of a major anticoagulant protein, tissue factor pathway inhibitor [27]. They also delay clot lysis through enhancing the action of thrombin-activatable fibrinolysis inhibitor [27]. Linear polyphosphates induce directly platelet aggregation and the long-chain variants are more potent in this action [28]. Linear polyphosphates modulate platelet activation indirectly, too. They induce von Willebrand factor release from endothelial cells through a high mobility group box 1 dependent mechanism resulting in platelet string formation [29]. Furthermore, the coexistence of neutrophils and platelets at the site of (immune)thrombosis allows for interplay between NET components and polyphosphates [1]. However, linear polyphosphates are unstable in circulation because of the presence of phosphatases. Thus, it is important to assess, if the particulate form of the polyphosphates that is more resistant to degradation can exert the same prothrombotic effects as their linear counterpart. To this end we produced a stable suspension of polyphosphate nanoparticles and in the present study we focused on one aspect of the multifaceted role of polyphosphates in thrombus formation, structure and lysis. We compared the effects of linear and nanoparticulate polyphosphates alone and in combination with NET components (DNA, histone) utilizing a simplified thrombin-mediated fibrin clot model.

Changes in the kinetics of clotting and lysis: The role of the nanoparticulate form emerges
When polyphosphates acted alone or in combination with DNA the linear form exerted the most pronounced effect on both clotting and lysis time 50 values. According to our present observations the main determinant of these PolyP effects was the number of particles and DNA did not significantly modify the PolyP effects on the clotting and lysis kinetics. However, when acting together with histone, a new perspective emerged. Firstly, histone and PolyPs modified each other's effects during both clotting and lysis. Secondly, histone exerted its effects on PolyP-Lin m and PolyP-NP in a different way: the former was hindered (during clotting) or slightly enhanced (during lysis), while the latter was remarkably reinforced during both clot formation and lysis. Based on these findings we conclude that: 1) differences in the intensity of interactions between DNA-PolyPs and histone-PolyPs can be attributed to the overall charges of the molecules: opposite charges in the case of histones and PolyPs are accompanied by stronger interactions; 2) the disparity of the histone-PolyP-Lin m and histone-PolyP-NP interplay in fibrin turnover suggests differences in their molecular interactions. The latter interpretation was confirmed by SPR measurements. Both linear (PolyP-Lin m ) and nanoparticulate PolyP bound to histone, but their SPR signals diverged suggesting that through stronger binding to the histone, the linear variants competed successfully with the non-covalent immobilization forces of the carboxymethyl-dextran matrix, whereas the weaker interactions of the PolyP-NP were not able to detach the complexes from the solid support. An important in vivo implication of this finding could be a more pronounced procoagulant and antifibrinolytic effects of polyphosphates in nanoparticulate form in extracellular compartments, where they are retained by the immobilized histone (e.g. in the meshwork of NETs) and enhance the prothrombotic effect of the latter in contrast to the linear alternates, which would rather contribute to the removal of the histone under flow.

Modification of fibrin structure: A plausible mechanism for the combined effects of histone and polyphosphates on the lytic stability of composite clots
According to earlier studies with pure fibrin, accelerated clot formation (e.g. by higher thrombin concentration) results in thinner fibers [30][31][32]. In our current study the fibrin fiber diameter was increased by histone, polyphosphates and their combinations despite accelerated clotting phase. Our earlier studies with composite clots have clarified the ultrastructural background of these effects using a small-angle X-ray scattering (SAXS) technique [2]. We have demonstrated that both histone and DNA cause fibrin fiber thickening based on distinct molecular mechanisms: histone interferes with the lateral organization of protofibrils, resulting in lower protofibril density and thicker fibers, while DNA preserves the protofibril-to-protofibril distance, but disrupts the regular longitudinal alignment of the fibrin monomers [2]. As for PolyP, it was shown earlier by others, that the linear form incorporates into polymerizing fibrin clots [33], which may be the reason for its fiber thickening effect. We have recently shown that linear polyphosphates enhance the fiber-thickening effect of histones [5], and our current results provide evidence that in the form of nanoparticles they are even stronger structural modifiers. The consequences of the changes of fiber size in terms of lytic susceptibility of fibrin depend on the cause of this structural modification. If higher thrombin activity generates fibrin monomers at higher rate, their fast polymerization results in densely branched fibrin meshwork composed of thin fibers that is resistant to lysis [34, reviewed in 35]. However, if the cause of changes in fibrin architecture is incorporation of modifier molecules, the thicker fibers are more resistant to lysis. Because the structure of the major fibrin-degrading protease, plasmin is optimal for the inter-protofibril distances within modifier-free fibrin fibers (reviewed in [23]), looser packaging of the protofibrils in the fibers would decrease its catalytic efficiency, as we have previously described for the breakdown of fibrin containing histones [2] or combination of histone and linear polyphosphate [5]. This interpretation is supported by the current result that the nanoparticulate PolyP with the strongest steric effect on the fiber geometry enhances stronger the anti-fibrinolytic action of histones than the linear variants. The known anti-fibrinolytic effect of histone-induced aggregation of fibrinogen [36] was observed in our experimental setting too, and could contribute as an independent factor to the lytic resistance of the composite clots.

Introducing a novel method to prepare stable PolyP-NPs
In recent years, different techniques were developed for generating stable nanoparticulate Pol-yPs. Colloidal confinement of PolyP on gold or attaching PolyP to silica nanoparticles resulted in enhanced procoagulant function with stability for even 24 weeks, thus potential candidates were developed for the treatment of internal injuries or a range of other haemorrhagic scenarios [37,38]. However, there is limited experience with generating pure PolyP-NPs, moreover, developed particles are stable only for a few hours [10]. Our paper presents a further improved version of previously described method for preparing pure PolyP-NPs [10,11]. The generated particles were of a size similar to those secreted by platelets in vivo (100-200 nm [6]), retained the former introduced polyphosphate functions on clot forming and lysis and were stable for at least 5 days stored in BSA-TBS at 4˚C.

Conclusions
In the past decade, the role of a secondary scaffold formed by activated neutrophil granulocytes has been conceived as an essential factor in thrombus evolution beyond the formation of a 3-dimensional fibrin network. The main effector of NETs, histone possesses several cytotoxic and prothrombotic effects and its overall impact is modified by polyanions (DNA, heparin derivatives and polyphosphates) in the microenvironment of clots. Heparinoids counteract, while DNA and polyphosphates enhance the clot stabilizing effects of histone. The focus of the present work was the comparison of the effects of linear and nanoparticulate polyphosphates alone and in combination with relevant NET components on thrombus formation, structure, and lysis. We found that the PolyP-histone interaction is more significant than the PolyP-DNA interplay probably due to differences in molecular charges: opposite charges are accompanied by stronger interactions. In addition, PolyP nanoparticles enhance the thrombus stabilizing effects of histone more effectively than the linear form. The underlying mechanism of this difference could be related to the weaker PolyP-NP/histone binding observed by us. The weak binding of PolyP-NP to histones allows for independent action of these fibrin-stabilizing factors with consequent additivity of their effects on fibrin fiber thickening and lytic resistance.
In contrast, the stronger linear PolyP-histone interaction counteracts more efficiently the accelerating effect of histones in clotting, but their complex formation abrogates the independence of their individual effects on fibrin structure and lysis and thus their combined action is not additive in the stabilization of fibrin. Therefore, nanoparticulate PolyP may be a relevant target of antithrombotic or thrombolytic agents and the novel method presented here for preparing stable PolyP-NPs may serve this line of investigation.